Clinical trials recruiting for HER2 Mutation-Related Tumors
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALX148 | 1 |
| BBO-10203 | 1 |
| Bevacizumab | 1 |
| FOLFOX | 1 |
| Fam-Trastuzumab Deruxtecan-Nxki | 1 |
| Fulvestrant | 1 |
| IAM1363 | 1 |
| Ribociclib | 1 |
| TTX-MC138 | 1 |
| Trastuzumab | 1 |
| Tucatinib | 1 |
| Zanidatamab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 3 |
| Texas | 3 |
| California | 2 |
| Colorado | 2 |
| Illinois | 2 |
| Massachusetts | 2 |
| Missouri | 2 |
| New York | 2 |
| Tennessee | 2 |
| Washington | 2 |
| Alabama | 1 |
| Arizona | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- PRE-ISPY Phase I/II Oncology Platform Program
Related conditions
Trials recruiting for HER2 Mutation-Related Tumors often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HER2 Mutation-Related Tumors trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.